PTHS relationship map
PTHS
Pelthos Therapeutics Inc.
Biofronteraunlisted—
Copper II 2020unlisted—
Ferrerunlisted—
Ferrer Internacionalunlisted—
Hatchtech Ptyunlisted—
Interquimunlisted—
Interquim, S.A.Uunlisted—
Ligandunlisted—
Orion Corporation ("Orion")unlisted—
University of North Carolina at Chapel Hill (UNC)unlisted—
← Buys from
PTHSPelthos Therapeutics Inc.
Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing
35.00% of PTHS rev10-K
Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing
35.00% of PTHS rev10-K
Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing
28.00% of PTHS rev10-K
Undisclosed wholesaler customer (28% of gross revenue)unnamed in filing
28.00% of PTHS rev10-K
Undisclosed wholesaler customer (26% of 2025 gross revenue)unnamed in filing
26.00% of PTHS rev10-K
Undisclosed wholesaler customer (26% of gross revenue)unnamed in filing
26.00% of PTHS rev10-K
—Sato Pharmaceuticalunlisted
Sells to →
Suppliers11Customers9
Biofronteraunlisted
Copper II 2020unlisted
Ferrerunlisted
Ferrer Internacionalunlisted
Hatchtech Ptyunlisted
Interquimunlisted
Interquim, S.A.Uunlisted
PTHS
Undisclosed wholesaler customer (35% of 2025 gross revenue)unnamed in filing35.00% of PTHS rev10-K
Undisclosed wholesaler customer (35% of gross revenue)unnamed in filing35.00% of PTHS rev10-K
Undisclosed wholesaler customer (28% of 2025 gross revenue)unnamed in filing28.00% of PTHS rev10-K
Undisclosed wholesaler customer (28% of gross revenue)unnamed in filing28.00% of PTHS rev10-K
Undisclosed wholesaler customer (26% of 2025 gross revenue)unnamed in filing26.00% of PTHS rev10-K
Undisclosed wholesaler customer (26% of gross revenue)unnamed in filing26.00% of PTHS rev10-K
suppliercustomerunlisted2°second-degree (Extended)
Thick line = filed share ·Moves · 17:52 ETSources